Alzheimer’s Drug with Modest Benefits Gets Green Light from FDA Advisers
The drug donanemab slows progression of symptoms in people with early stages of Alzheimer’s disease, but questions linger about the durability of its effect
This Is Your Brain on Climate Change
Extreme heat caused by climate change can exacerbate a variety of neurological ailments, from Alzheimer’s disease to migraines to epilepsy, new research shows
Does Long-Term Benadryl Use Increase Dementia Risk?
Benadryl, which contains diphenhydramine, is a drugstore mainstay and just one medication out of many that could possibly damage brain health
Growth Hormone Injections May Have ‘Seeded’ Alzheimer’s in Some People, Study Suggests
Injections of no-longer-used growth hormone derived from cadavers may have “seeded” Alzheimer’s in some people, small study suggests
Forgotten Memories May Remain Intact in the Brain
Everyday lapses in memory can be a part of learning
Alzheimer’s Drug Donanemab Helps Most When Taken Early in Disease
An Alzheimer’s drug that attacks the protein amyloid does not work as well in people with more advanced disease
How Dangerous Are Soccer Concussions? They May Cause Lasting Damage
As the 2023 Women’s World Cup kicks off, repeated concussions and head injuries in the sport raise discussion about the lifelong consequences on the brain
A Rare Form of Dementia Can Unleash Creativity
Frontotemporal dementia can release the creative potential of the brain’s visual areas
Understanding Frontotemporal Dementia, the Leading Cause of Dementia in People under Age 60
There is no cure for FTD, the disease that actor Bruce Willis was recently diagnosed with, but new research suggests some future therapies
Heralded Alzheimer’s Drug Works, but Safety Concerns Loom
Eisai and Biogen share clinical trial data confirming that lecanemab slows mental decline amid reports of potentially related deaths
Treating Alzheimer’s Before It Takes Hold
Researchers are giving drugs to healthy people in hope of clearing away toxic proteins in the brain and preventing neurodegeneration.
U.S. Alzheimer's Deaths Jump 54 Percent; More Dying at Home
Trend reflects the nation’s aging population and increasing life expectancy